Key facts
- This page summarizes Bradley A. Feld's Form 4 filing for Molekule Group, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Jan 2023, 17:23.
Bradley A. Feld - 12 Jan 2023 Form 4 Insider Report for Molekule Group, Inc.
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 12 Jan 2023
- Net transaction value
- $0
- Reporting owner signature
- /s/ Bradley A. Feld
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Bradley A. Feld filed Form 4 for Molekule Group, Inc. on 17 Jan 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MKUL
transaction
Common Stock
Award
- Transaction value
- Shares
- +7,217,710
- Change %
- Price
- Shares after
- 7,217,710
- Date
- 12 Jan 2023
- Ownership
- By Foundry Group Next, L.P.
- Footnotes
- F1, F2, F3
MKUL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 92,000
- Date
- 12 Jan 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Received pursuant to the Agreement and Plan of Merger dated as of October 3, 2022 (the "Merger Agreement") by and among the Issuer, Air King Merger Sub Inc., a Delaware corporation and direct wholly-owned subsidiary of the Issuer ("Merger Sub"), and Molekule, Inc., a Delaware corporation ("Molekule"). Pursuant to the Merger Agreement, Merger Sub merged with and into Molekule, with Molekule continuing as the surviving entity and a wholly-owned subsidiary of the Issuer (the "Merger").
Footnote F2
Received in the Merger in exchange for 53,725,891 shares of capital stock of Molekule held by Foundry Group Next, L.P. ("Foundry").
Footnote F3
Shares are held by Foundry. FG Next GP, L.L.C. ("Foundry GP") is the general partner of Foundry and may be deemed to beneficially own these shares. The Reporting Person is a managing member of Foundry GP, and may be deemed to share voting and investment power over these shares. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.